Upadacitinib Improves Giant Cell Arteritis in Phase 3 Trial
Results from the phase 3 SELECT-GCA study revealed that the JAK inhibitor…
Eliminate Stigma As Expert Unveils Facts And Myths
During Post-Traumatic Stress Disorder Awareness Month, Natalie Rosado educates about PTSD, dispelling…
Better Health Raises $14M To Reach More Patients with Chronic Conditions
Better Health, a platform for patients with chronic conditions, has secured $14…
Access to and cost of healthcare pose concerns for Irish consumers
A survey of Irish consumers shows high levels of concern about physical…
Funding Instability Plagues Program That Brings Docs to Underserved Areas
Diana Perez, a medical resident at the Family Health Center of Harlem,…
Oncologist receives Szent-Györgyi Prize for groundbreaking research discoveries
Dennis J. Slamon, MD, PhD, received the Szent-Györgyi Prize for Progress in…
Novartis arthritis drug is unaffordable, Colorado state board decides
The Colorado Prescription Drug Affordability Board has deemed Novartis' blockbuster arthritis drug,…
Disclosure programmes in the US—an inadequate response to medical error
Gail Mazur Handley is a patient advocate who believes in the importance…
Novel gene-editing therapy continues to show positive results in sickle cell patients
Researchers presented positive findings from the RUBY Trial, focusing on a one-time…
Tackling challenges in childhood arthritis transition to adult care
Rheumatological diseases, including juvenile idiopathic arthritis (JIA), can affect children, with a…